Effective stroke management connects the dots between caregivers at critical moments in stroke care pathways. We are with you, focused on making a life-saving difference for your patients.
Complexity holds back speed in stroke patient management. A network of separate yet highly interdependent workflows must work fluidly together. Gaps in information, communication and access to stroke expertise can cause delays that have tragic consequences for stroke patients. Our innovations are designed to support better teamwork and collaboration, providing the information and tools that help you deliver time-sensitive, life-saving care.
We bridge the gaps between caregivers across the stroke care pathway – at each vital step. By rapidly providing valuable insights at key moments, our integrated stroke solutions reduce the impact of stroke events.
Despite a broader window of eligibility for mechanical thrombectomy, one third of stroke patients still become ineligible due to time lost.3
We are pioneering Direct to Angio Suite (DTAS) workflows to
drastically reduce stroke treatment time and improve
outcomes for these patients. Follow our progress during the
WE-TRUST clinical trial.
Despite a broader window of eligibility for mechanical thrombectomy, one third of stroke patients still become ineligible due to time lost.3
We are pioneering Direct to Angio Suite (DTAS) workflows to
drastically reduce stroke treatment time and improve
outcomes for these patients. Follow our progress during the
WE-TRUST clinical trial.
"The value for the patient is created across the full cycle of care – from their prehospital experience, throughout their time in the hospital, as they are teed-up for discharge, and during their recovery period at home.”
Atul Gupta
Chief Medical Officer, Philips Image Guided Therapy
No longer do you have to choose between viewing anatomical structures and identifying material composition.
Philips partnered with medtech firm Nicolab, integrating its cloud based stroke triage and management solution StrokeViewer into Philips’ end-to-end stroke care pathway.
Connect telemedicine resources across the health system to focus on more timely interventions for stroke patients.
How can you think differently when managing stroke care? Think about faster access, improved triage, and better clinical and economic outcomes.
WE-TRUST Study is a multi-center randomized clinical trial to assess the impact of a ‘Direct to Angio Suite’ (DTAS) workflow on stroke patient outcomes.
Discover WE-TRUSTPhilips image-guided therapy offers the Neurovascular suite with a flexible portfolio of integrated technologies, services, and neuro accessories that puts you in firm control.
Discover Neurovascular care LINNC AMERICAS | MIAMA, USA | FEBRUARY 22-23, 2024 |
ECR | VIENNA, AUSTRIA | FEBRUARY 28 – MARCH 3, 2024 |
SLICE NEXT FRONTIERS | ONLINE | APRIL 3-4, 2024 |
WLNC/iCure Stroke | ISTANBUL, TURKEY | MAY 7-10, 2024 |
ESOC | BASEL, SWITSERLAND | MAY 15 - 17, 2024 |
LINNC PARIS | PARIS, FRANCE | JUNE 3-5, 2024 |
SNIS | COLORADO SPRINGS, USA | JULY 22-26, 2024 |
ESMINT | MARSEILLE, FRANCE | SEPTEMBER 4-6, 2024 |
WFITN | NEW YORK, USA | OCTOBER 6-10, 2024 |
SLICE WORLDWIDE | ONLINE | OCTOBER 17-18, 2024 |
WORLD STROKE CONGRESS | ABU DHABI, UAE | OCTOBER 23 - 26, 2024 |
LINNC ASIA | BANGKOK, THAILAND | OCTOBER 25-26, 2024 |
1. 52% out of office hours: UK study. N = 45000, (Campbell, J. T., Bray, B. D., Hoffman, A. M., Kavanagh, S. J., Rudd, A. G., Tyrrell, P. J., & Intercollegiate Stroke Working Party (2014). The effect of out of hours presentation with acute stroke on processes of care and outcomes: analysis of data from the Stroke Improvement National Audit Programme (SINAP). PloS one, 9(2), e87946. https://doi.org/10.1371/journal.pone.0087946) 2. 60% out of office hours: Scotland study N = 52000, (Turner M, Barber M, Dodds H on behalf of the Scottish Stroke Care Audit, et al. Stroke patients admitted within normal working hours are more likely to achieve process standards and to have better outcomes. Journal of Neurology, Neurosurgery & Psychiatry 2016;87:138-143.) 3. Nannoni S, Strambo D, Sirimarco G, et al. Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center Journal of NeuroInterventional Surgery 2020;12:842-847.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.